Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Grifols, Talecris Sign Consent Agreement for Merger | Contract Pharma

What are you searching for?

Sign in
Breaking News

Grifols, Talecris Sign Consent Agreement for Merger

Grifols, S.A. and Talecris Biotherapeutics Holdings Corp. have signed a consent agreement with the U.S. Federal Trade Commission (FTC) outlining the conditions for Grifols’ acquisition of Talecris.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Grifols, S.A. and Talecris Biotherapeutics Holdings Corp. have signed a consent agreement with the U.S. Federal Trade Commission (FTC) outlining the conditions for Grifols’ acquisition of Talecris. Grifols has agreed to the sale of select assets and has entered into certain commercial, lease and manufacturing agreements with the Italian company Kedrion for as many as seven years.

Kedrion and Grifols will have a contract manufacturing agreement to fractionate and purify Kedrion’s plasma and to deliver IVIG and Albumin under Kedrion’s private label, and Factor VIII under the trade name Koate, for sale in the U.S.

Grifols will sell its Melville, N.Y. fractionation facility to Kedrion and Grifols will manage the facility for as long as four years under a lease agreement with Kedrion. Grifols will also sell Talecris’ U.S. FVIII business (Koate) and two Talecris plasma collection centers to Kedrion.

The consent agreement remains subject to approval by the FTC and until the acquisition is finalized, both companies remain independent and will conduct business as usual.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters